Latest Australian Market Entry News

Algorae Pharmaceuticals has reached a key regulatory milestone as the TGA accepts its initial registration dossier, paving the way for potential commercialisation of its generic medicines in Australia and New Zealand.

ClearVue Technologies has achieved a key international certification for its innovative solar panels and is deepening its strategic alliance with Helios Power, setting the stage for expanded commercial deployment in the building-integrated photovoltaics market.

RLF AgTech Ltd has reported a record December quarter with $10.4 million in cash receipts, driven by strong performances across its LiquaForce, China, and newly operational Australian divisions. Positive field trial results in Vietnam and ongoing expansion in Southeast Asia underpin the company’s growth outlook.

Proteomics International Laboratories has clarified that no undisclosed information explains its recent share price jump, pointing instead to recent Medicare reimbursement decisions and key product developments.

Range International Limited has reported its strongest quarterly sales to date, driven by its Re>Pal Indonesia operations, while gearing up to double production capacity with a new factory and pivoting to a pallet rental model.

WhiteHawk Limited reported solid Q2 revenue growth with new US contracts and is advancing its Australian market entry, while managing cash flow challenges.

Cardiex Limited has formally lodged its CONNEQT Pulse device with Australia's Therapeutics Goods Administration, marking a critical step toward regulatory approval and market expansion.

Cardiex reports strong early sales momentum for its CONNEQT Pulse device with approximately 3,000 units sold or contracted since its mid-January launch, supported by innovative app features and operational efficiencies. Despite regulatory delays in the US pharma sector and tariff challenges, the company is positioned for scalable growth and category leadership in preventative cardiovascular care.

OncoSil Medical has achieved a key regulatory milestone with MDR certification from BSI, removing post-market restrictions and streamlining its commercial operations across Europe. This approval also paves the way for renewed efforts to enter the Australian market.